SecBot SecBot
SECBOTREPLAY Home › Report › VKTX

VKTX · Viking Therapeutics is holding its 2026 annual shareholder meeting to…

Viking Therapeutics, Inc. · DEFA14A filed Apr 1, 2026 at 16:15 ET

At the news

NEUTRALIMPACT 2/10

DEFA14A filed Apr 1, 2026 at 16:15 ET

Viking Therapeutics is holding its 2026 annual shareholder meeting to vote on director elections, auditor selection, and executive compensation. This is a routine annual filing with no material financial or operational updates.

  • Annual shareholder meeting scheduled for May 19, 2026
  • Voting on election of two Class II directors: J. Matthew Singleton and S. Kathryn Rouan, Ph.D.
  • Ratification of CBIZ CPAS P.C. as independent auditors
  • Advisory vote on executive compensation

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access